BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3260071)

  • 21. Isolation and characterization of porcine alpha 1-proteinase inhibitor. Leukocyte elastase-inhibitor complexes in porcine blood, I.
    Geiger R; Leysath G; Fritz H
    J Clin Chem Clin Biochem; 1985 Oct; 23(10):637-43. PubMed ID: 3877780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of alpha 1 proteinase inhibitor from human plasma fraction IV-1 by ion exchange chromatography.
    Chen SX; Hammond DJ; Lang JM; Lebing WR
    Vox Sang; 1998; 74(4):232-41. PubMed ID: 9691404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and properties of human plasma alpha-1-proteinase inhibitor.
    Pannell R; Johnson D; Travis J
    Biochemistry; 1974 Dec; 13(26):5439-45. PubMed ID: 4547976
    [No Abstract]   [Full Text] [Related]  

  • 25. Proteinase inhibitors in rat serum. Purification and partial characterization of three functionally distinct trypsin inhibitors.
    Kuehn L; Rutschmann M; Dahlmann B; Reinauer H
    Biochem J; 1984 Mar; 218(3):953-9. PubMed ID: 6609702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparative isoelectric focusing in agarose.
    Chapuis-Cellier C; Arnaud P
    Anal Biochem; 1981 May; 113(2):325-31. PubMed ID: 6792947
    [No Abstract]   [Full Text] [Related]  

  • 27. An improved method for large scale purification of human holo-transcobalamin II.
    Van Kapel J; Loef BG; Lindemans J; Abels J
    Biochim Biophys Acta; 1981 Sep; 676(3):307-13. PubMed ID: 6793085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and analysis of human alpha1-antitrypsin concentrate by a new immunoaffinity chromatography.
    Zhang X; Hou Y; Ding X; Ye S; Cao H; Wang Z; Du X; Xie YW; Li C
    Prep Biochem Biotechnol; 2014 Oct; 44(7):725-37. PubMed ID: 24279822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Möllby R; Wadström T
    Biochim Biophys Acta; 1973 Oct; 321(2):569-84. PubMed ID: 4357667
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunofixation after electrofocusing: improved method for specific detection of serum proteins with determination of isoelectric points. I. Immunofixation print technique for detection of alpha-1-protease inhibitor.
    Arnaud P; Wilson GB; Koistinen J; Fudenberg HH
    J Immunol Methods; 1977; 16(3):221-31. PubMed ID: 17639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation and virus safety of alpha 1-proteinase inhibitor.
    Coan MH; Dobkin MB; Brockway WJ; Mitra G
    Eur Respir J Suppl; 1990 Mar; 9():35s-38s. PubMed ID: 2340049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of sheep alpha-1-proteinase inhibitor. Important differences from the human protein.
    Sinha U; Sinha S; Janoff A
    Am Rev Respir Dis; 1988 Mar; 137(3):558-63. PubMed ID: 3257851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and purification of an abnormal protein from plasma of patients with rheumatoid arthritis.
    Oda O; Maeda K; Yamaga H; Kanamono Y; Iwata H; Miura T; Yoshida M; Miyata S; Ohta K; Yamanaka N
    Clin Chim Acta; 1988 Jul; 175(3):321-8. PubMed ID: 3416492
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report.
    Moser KM; Smith RM; Spragg RG; Tisi GM
    Am J Med; 1988 Jun; 84(6A):70-4. PubMed ID: 3260074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
    Smith RM; Traber LD; Traber DL; Spragg RG
    J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large scale chromatographic purification of alpha 1-antitrypsin from human plasma supernatant II + III.
    Burnouf T; Constans J; Clerc A; Descamps J; Martinache L; Goudemand M
    Dev Biol Stand; 1987; 67():31-8. PubMed ID: 3497064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convenient high-resolution isoelectric focusing (IEF) method for the separation of alpha1-proteinase inhibitor (A1PI) isoforms in A1PI concentrates.
    Weber A; Engelmaier A; Owen MC; Schwarz HP; Turecek PL
    J Pharm Biomed Anal; 2007 Sep; 45(1):107-111. PubMed ID: 17629652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase.
    Morihara K; Tsuzuki H; Harada M; Iwata T
    J Biochem; 1984 Mar; 95(3):795-804. PubMed ID: 6427201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunoelectrophoretic identification of proteins separated by zonal electrophoresis and isoelectric focusing].
    Zhabin SG; Zorin NA; Zaĭtseva SV
    Vopr Med Khim; 1990; 36(2):91-3. PubMed ID: 2363269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.